Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve and take on record the Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Denis Chem Lab Ltd has notified BSE of a board meeting scheduled for May 30, 2026, to consider and approve the audited standalone financial results for FY 2025-26 (ending March 31, 2026). The meeting will also consider recommending a final dividend, if any, for the same period. The company, a manufacturer of parenteral products (injectable pharmaceuticals), has confirmed that the trading window remains closed for designated persons until 48 hours after the results are declared. This is a standard pre-result announcement notice and does not contain any actual financial figures or performance data.
This is a routine procedural filing announcing when the board will review audited financials and consider dividend. No impact can be assessed until actual results are disclosed after the meeting.